Group | Stressor dose (μg/kg/min) | MBFi ratio (stress/rest) | MVO2ratio (stress/rest) | OEFi ratio (stress/rest) | RPP ratio (stress/rest) | sMFR (RPP-adjusted) |
---|---|---|---|---|---|---|
Normal | NE 3.2 | 1.68 ± 0.42 | 1.58 ± 0.28 | 0.99 ± 0.29 | 1.19 ± 0.10 | 1.39 ± 0.35 (25%) |
SB 0.2 | 1.39 ± 0.27 | 1.37 ± 0.15 | 1.00 ± 0.10 | 1.00 ± 0.02* | 1.39 ± 0.27 (19%) | |
SB 1.0 | 1.75 ± 0.25*** | 1.73 ± 0.23*** | 1.00 ± 0.14 | 0.98 ± 0.02* | 1.78 ± 0.25*** (14%) | |
PHE + NE 3.2 | 1.61 ± 0.51 | 1.95 ± 0.45 | 1.27 ± 0.35 | 0.89 ± 0.15* | 1.81 ± 0.57 (32%) | |
eNOS knockout | NE 3.2 | 1.12 ± 0.23* | 1.57 ± 0.34 | 1.46 ± 0.50 | 1.13 ± 0.04 | 0.99 ± 0.20* (20%) |
NOS inhibition | NE 3.2 | 1.03 ± 0.23* | 1.35 ± 0.20 | 1.35 ± 0.29 | 1.07 ± 0.02* | 0.96 ± 0.22* (23%) |
SB 0.2 | 0.99 ± 0.15*,** | 1.17 ± 0.08*,** | 1.20 ± 0.12** | 1.00 ± 0.03* | 0.98 ± 0.15*,** (15%) | |
SB 1.0 | 1.38 ± 0.17**,*** | 1.58 ± 0.37*** | 1.16 ± 0.29 | 0.99 ± 0.02* | 1.39 ± 0.17**,*** (12%) |